0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

TREATMENT OF CHOREA WITH PHENYL-ETHYL-HYDANTOIN

J. D. PILCHER, M.D.; H. J. GERSTENBERGER, M.D.
Am J Dis Child. 1930;40(6):1239-1249. doi:10.1001/archpedi.1930.01940060079007.
Text Size: A A A
Published online

Phenyl-ethyl-hydantoin was introduced in Germany about 1918 as a hypnotic and general sedative. Curschmann,1 in one of the earliest reports, was favorably impressed with its use in adults for sleeplessness from a variety of causes, and other reports soon followed. As so frequently happens, favorable reports tended toward carelessness in dosage, and numerous cases of poisoning soon occurred from the narcotic action. In adults, the drug, usually after repeated dosage, occasionally causes a rise in temperature up to 40 C. (104 F.) and a morbilliform exanthem which seems to be without significance; some authors have had considerable experience with the drug without meeting this action. However, the rash and fever occur in the majority of children treated with this drug for chorea, and the favorable results reported seem to depend on the production of these reactions. The first use of phenyl-ethyl-hydantoin for chorea minor is attributed to E. Roeder,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();